世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Kidney Cancer Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3318 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、腎臓がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2））、用途別市場規模（病院、研究所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腎臓がん治療薬の市場動向 ・企業の競争状況、市場シェア ・腎臓がん治療薬の種類別市場規模（血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2）） ・腎臓がん治療薬の用途別市場規模（病院、研究所、診断センター、その他） ・腎臓がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・腎臓がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腎臓がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腎臓がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・腎臓がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen/Allergan、Argos Therapeutics、AstraZeneca、Aveo Pharmaceuticals、Bayer、Exelixis、Incyte、Merck、Roche、Pfizer、Bristol-Myers Squibb、Eisai、Prometheus Labs、Novartis） ・結論

Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.
Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits.

Market Analysis and Insights: Global Kidney Cancer Treatment Drugs Market
The global Kidney Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kidney Cancer Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kidney Cancer Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kidney Cancer Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kidney Cancer Treatment Drugs market.

Global Kidney Cancer Treatment Drugs Scope and Market Size
Kidney Cancer Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)

Segment by Application
Hospitals
Research Institutes
Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen/Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Aveo Pharmaceuticals
Bayer
Eisai

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Angiogenesis Inhibitors
1.2.3 mTOR Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine Immunotherapy (IL-2)
1.3 Market by Application
1.3.1 Global Kidney Cancer Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Kidney Cancer Treatment Drugs Market Perspective (2016-2027)
2.2 Kidney Cancer Treatment Drugs Growth Trends by Regions
2.2.1 Kidney Cancer Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kidney Cancer Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Kidney Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Kidney Cancer Treatment Drugs Industry Dynamic
2.3.1 Kidney Cancer Treatment Drugs Market Trends
2.3.2 Kidney Cancer Treatment Drugs Market Drivers
2.3.3 Kidney Cancer Treatment Drugs Market Challenges
2.3.4 Kidney Cancer Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Treatment Drugs Players by Revenue
3.1.1 Global Top Kidney Cancer Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Kidney Cancer Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Kidney Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Treatment Drugs Revenue
3.4 Global Kidney Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Kidney Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Treatment Drugs Revenue in 2020
3.5 Kidney Cancer Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Kidney Cancer Treatment Drugs Product Solution and Service
3.7 Date of Enter into Kidney Cancer Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Kidney Cancer Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Kidney Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Kidney Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Kidney Cancer Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Kidney Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Kidney Cancer Treatment Drugs Market Size (2016-2027)
6.2 North America Kidney Cancer Treatment Drugs Market Size by Type
6.2.1 North America Kidney Cancer Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Kidney Cancer Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Kidney Cancer Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Kidney Cancer Treatment Drugs Market Size by Application
6.3.1 North America Kidney Cancer Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Kidney Cancer Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Kidney Cancer Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Kidney Cancer Treatment Drugs Market Size by Country
6.4.1 North America Kidney Cancer Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Kidney Cancer Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Kidney Cancer Treatment Drugs Market Size (2016-2027)
7.2 Europe Kidney Cancer Treatment Drugs Market Size by Type
7.2.1 Europe Kidney Cancer Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Kidney Cancer Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Kidney Cancer Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Kidney Cancer Treatment Drugs Market Size by Application
7.3.1 Europe Kidney Cancer Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Kidney Cancer Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Kidney Cancer Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Kidney Cancer Treatment Drugs Market Size by Country
7.4.1 Europe Kidney Cancer Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Kidney Cancer Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Kidney Cancer Treatment Drugs Market Size (2016-2027)
9.2 Latin America Kidney Cancer Treatment Drugs Market Size by Type
9.2.1 Latin America Kidney Cancer Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Kidney Cancer Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Kidney Cancer Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Kidney Cancer Treatment Drugs Market Size by Application
9.3.1 Latin America Kidney Cancer Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Kidney Cancer Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Kidney Cancer Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Kidney Cancer Treatment Drugs Market Size by Country
9.4.1 Latin America Kidney Cancer Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Kidney Cancer Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen/Allergan
11.1.1 Amgen/Allergan Company Details
11.1.2 Amgen/Allergan Business Overview
11.1.3 Amgen/Allergan Kidney Cancer Treatment Drugs Introduction
11.1.4 Amgen/Allergan Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.1.5 Amgen/Allergan Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Details
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics Kidney Cancer Treatment Drugs Introduction
11.2.4 Argos Therapeutics Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.2.5 Argos Therapeutics Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Kidney Cancer Treatment Drugs Introduction
11.3.4 AstraZeneca Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Aveo Pharmaceuticals
11.4.1 Aveo Pharmaceuticals Company Details
11.4.2 Aveo Pharmaceuticals Business Overview
11.4.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Introduction
11.4.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.4.5 Aveo Pharmaceuticals Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Kidney Cancer Treatment Drugs Introduction
11.5.4 Bayer Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Exelixis
11.6.1 Exelixis Company Details
11.6.2 Exelixis Business Overview
11.6.3 Exelixis Kidney Cancer Treatment Drugs Introduction
11.6.4 Exelixis Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.6.5 Exelixis Recent Development
11.7 Incyte
11.7.1 Incyte Company Details
11.7.2 Incyte Business Overview
11.7.3 Incyte Kidney Cancer Treatment Drugs Introduction
11.7.4 Incyte Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.7.5 Incyte Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Kidney Cancer Treatment Drugs Introduction
11.8.4 Merck Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Kidney Cancer Treatment Drugs Introduction
11.9.4 Roche Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.9.5 Roche Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Kidney Cancer Treatment Drugs Introduction
11.10.4 Pfizer Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Introduction
11.11.4 Bristol-Myers Squibb Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Eisai
11.12.1 Eisai Company Details
11.12.2 Eisai Business Overview
11.12.3 Eisai Kidney Cancer Treatment Drugs Introduction
11.12.4 Eisai Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.12.5 Eisai Recent Development
11.13 Prometheus Labs
11.13.1 Prometheus Labs Company Details
11.13.2 Prometheus Labs Business Overview
11.13.3 Prometheus Labs Kidney Cancer Treatment Drugs Introduction
11.13.4 Prometheus Labs Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.13.5 Prometheus Labs Recent Development
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis Kidney Cancer Treatment Drugs Introduction
11.14.4 Novartis Revenue in Kidney Cancer Treatment Drugs Business (2016-2021)
11.14.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Angiogenesis Inhibitors
Table 3. Key Players of mTOR Inhibitors
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Cytokine Immunotherapy (IL-2)
Table 6. Global Kidney Cancer Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Kidney Cancer Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Kidney Cancer Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Kidney Cancer Treatment Drugs Market Share by Regions (2016-2021)
Table 10. Global Kidney Cancer Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Kidney Cancer Treatment Drugs Market Share by Regions (2022-2027)
Table 12. Kidney Cancer Treatment Drugs Market Trends
Table 13. Kidney Cancer Treatment Drugs Market Drivers
Table 14. Kidney Cancer Treatment Drugs Market Challenges
Table 15. Kidney Cancer Treatment Drugs Market Restraints
Table 16. Global Kidney Cancer Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Kidney Cancer Treatment Drugs Market Share by Players (2016-2021)
Table 18. Global Top Kidney Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Treatment Drugs as of 2020)
Table 19. Ranking of Global Top Kidney Cancer Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Kidney Cancer Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Kidney Cancer Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Kidney Cancer Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kidney Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Kidney Cancer Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Kidney Cancer Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Kidney Cancer Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Kidney Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Kidney Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Kidney Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Kidney Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Kidney Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Kidney Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Kidney Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Kidney Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Kidney Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Kidney Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Kidney Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Kidney Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Kidney Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Kidney Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Kidney Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Kidney Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Kidney Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Kidney Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen/Allergan Company Details
Table 64. Amgen/Allergan Business Overview
Table 65. Amgen/Allergan Kidney Cancer Treatment Drugs Product
Table 66. Amgen/Allergan Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 67. Amgen/Allergan Recent Development
Table 68. Argos Therapeutics Company Details
Table 69. Argos Therapeutics Business Overview
Table 70. Argos Therapeutics Kidney Cancer Treatment Drugs Product
Table 71. Argos Therapeutics Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 72. Argos Therapeutics Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Kidney Cancer Treatment Drugs Product
Table 76. AstraZeneca Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Aveo Pharmaceuticals Company Details
Table 79. Aveo Pharmaceuticals Business Overview
Table 80. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product
Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 82. Aveo Pharmaceuticals Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Kidney Cancer Treatment Drugs Product
Table 86. Bayer Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Exelixis Company Details
Table 89. Exelixis Business Overview
Table 90. Exelixis Kidney Cancer Treatment Drugs Product
Table 91. Exelixis Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 92. Exelixis Recent Development
Table 93. Incyte Company Details
Table 94. Incyte Business Overview
Table 95. Incyte Kidney Cancer Treatment Drugs Product
Table 96. Incyte Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 97. Incyte Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Kidney Cancer Treatment Drugs Product
Table 105. Roche Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 106. Roche Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Kidney Cancer Treatment Drugs Product
Table 110. Pfizer Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product
Table 115. Bristol-Myers Squibb Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Eisai Company Details
Table 118. Eisai Business Overview
Table 119. Eisai Kidney Cancer Treatment Drugs Product
Table 120. Eisai Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 121. Eisai Recent Development
Table 122. Prometheus Labs Company Details
Table 123. Prometheus Labs Business Overview
Table 124. Prometheus Labs Kidney Cancer Treatment Drugs Product
Table 125. Prometheus Labs Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 126. Prometheus Labs Recent Development
Table 127. Novartis Company Details
Table 128. Novartis Business Overview
Table 129. Novartis Kidney Cancer Treatment Drugs Product
Table 130. Novartis Revenue in Kidney Cancer Treatment Drugs Business (2016-2021) & (US$ Million)
Table 131. Novartis Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Angiogenesis Inhibitors Features
Figure 3. mTOR Inhibitors Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Cytokine Immunotherapy (IL-2) Features
Figure 6. Global Kidney Cancer Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Kidney Cancer Treatment Drugs Report Years Considered
Figure 12. Global Kidney Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Kidney Cancer Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Kidney Cancer Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Kidney Cancer Treatment Drugs Market Share by Regions (2022-2027)
Figure 16. Global Kidney Cancer Treatment Drugs Market Share by Players in 2020
Figure 17. Global Top Kidney Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Treatment Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Treatment Drugs Revenue in 2020
Figure 19. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Kidney Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 23. North America Kidney Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 24. North America Kidney Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 25. United States Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Kidney Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 29. Europe Kidney Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 30. Europe Kidney Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 31. Germany Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Kidney Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Kidney Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Kidney Cancer Treatment Drugs Market Share by Region (2016-2027)
Figure 41. China Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Kidney Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Kidney Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Kidney Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Kidney Cancer Treatment Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Kidney Cancer Treatment Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Kidney Cancer Treatment Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Kidney Cancer Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen/Allergan Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 61. Argos Therapeutics Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 63. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 65. Exelixis Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 66. Incyte Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 71. Eisai Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 72. Prometheus Labs Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---